Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lobke C M Hensen

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|September 22, 2020
Adenovirus Receptor Expression in Cancer and Its Multifaceted Role in Oncolytic Adenovirus TherapyLobke C M Hensen, Rob C Hoeben, Selas T F Bots
Human Vaccines & Immunotherapeutics|June 1, 2026
T-cell responses to primary SARS-CoV-2 vaccination in Down syndrome - From childhood to adulthoodLobke C M Hensen, Bianca M M Streng, Femke van Wijk, et al.
Cancer Immunology, Immunotherapy : CII|July 5, 2024
In vitro T cell responses to PD-1 blockade are reduced by IFN-α but do not predict therapy response in melanoma patientsLaura M Timmerman, Lobke C M Hensen, Mick J M van Eijs, et al.
Molecular Therapy. Oncology|February 3, 2026
Improved oncolytic and immunostimulatory activity of the spontaneous <i>jin-3</i> reovirus mutant in preclinical bladder cancer modelsArjanneke F van de Merbel, Maaike H van der Mark, Lobke C M Hensen, et al.
Vaccine|December 25, 2025
Antibody concentration and function following SARS-CoV-2 vaccination decrease with age in adults and children with Down syndromeBianca M M Streng, Lobke C M Hensen, Eveline M Delemarre, et al.
Human Vaccines & Immunotherapeutics|November 6, 2025
T-cell responses to SARS-CoV-2 vaccinations in adults with Down syndrome - a prospective cohort studyLobke C M Hensen, Bianca M M Streng, Femke van Wijk, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|September 22, 2020
Adenovirus Receptor Expression in Cancer and Its Multifaceted Role in Oncolytic Adenovirus TherapyLobke C M Hensen, Rob C Hoeben, Selas T F Bots
Human Vaccines & Immunotherapeutics|June 1, 2026
T-cell responses to primary SARS-CoV-2 vaccination in Down syndrome - From childhood to adulthoodLobke C M Hensen, Bianca M M Streng, Femke van Wijk, et al.
Cancer Immunology, Immunotherapy : CII|July 5, 2024
In vitro T cell responses to PD-1 blockade are reduced by IFN-α but do not predict therapy response in melanoma patientsLaura M Timmerman, Lobke C M Hensen, Mick J M van Eijs, et al.
Molecular Therapy. Oncology|February 3, 2026
Improved oncolytic and immunostimulatory activity of the spontaneous <i>jin-3</i> reovirus mutant in preclinical bladder cancer modelsArjanneke F van de Merbel, Maaike H van der Mark, Lobke C M Hensen, et al.
Vaccine|December 25, 2025
Antibody concentration and function following SARS-CoV-2 vaccination decrease with age in adults and children with Down syndromeBianca M M Streng, Lobke C M Hensen, Eveline M Delemarre, et al.
Human Vaccines & Immunotherapeutics|November 6, 2025
T-cell responses to SARS-CoV-2 vaccinations in adults with Down syndrome - a prospective cohort studyLobke C M Hensen, Bianca M M Streng, Femke van Wijk, et al.
Pageof 1